Pfizer’s vaccine chief on Omicron, mix-and-match boosters, and being prepared for the unknown
Pfizer and partner BioNTech announced Wednesday that new data show that antibodies generated by their Covid vaccine appear less effective against the Omicron variant than other variants, but that a third booster dose likely provides sufficient antibody protection.
Those data are very preliminary.
